SEC Form 3 · accession 0001721697-17-000001
LifeMD, Inc. · LFMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Borenstein
Director
Period of report
Oct 16, 2017
Accepted (ET)
Nov 13, 2017 · 9:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000948320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01F1 | holding | — | — | — | 217,390 | I | Pilaris Laboratories, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $0.40 | holding | — | — | — | Apr 24, 2017 | Apr 23, 2020 | Common Stock, par value $0.01 | 108,696 | — | I |
Explanation of responses
- F1Mr. Bornstein is the holder of a 50% equity interest in Pilaris Laboratories, LLC. The reporting person disclaims beneficial ownership of the reported securities held by such LLC except to the extent of his pecuniary interest therein.